ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 146 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $3,385,000 | +13.4% | 179,500 | -29.2% | 0.00% | 0.0% |
| Q2 2019 | $2,984,000 | +62.8% | 253,550 | +88.9% | 0.00% | +100.0% |
| Q1 2019 | $1,833,000 | +1597.2% | 134,250 | +1178.6% | 0.00% | – |
| Q4 2018 | $108,000 | -78.4% | 10,500 | -65.0% | 0.00% | -100.0% |
| Q3 2018 | $500,000 | +216.5% | 30,000 | +200.0% | 0.00% | – |
| Q2 2018 | $158,000 | -66.7% | 10,000 | -31.0% | 0.00% | -100.0% |
| Q3 2016 | $475,000 | -4.8% | 14,500 | -27.5% | 0.00% | 0.0% |
| Q2 2016 | $499,000 | -16.1% | 20,000 | +11.1% | 0.00% | 0.0% |
| Q4 2015 | $595,000 | -43.8% | 18,000 | -10.0% | 0.00% | 0.0% |
| Q2 2015 | $1,059,000 | +62.2% | 20,000 | -10.9% | 0.00% | 0.0% |
| Q4 2014 | $653,000 | – | 22,450 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,130 | $34,629,000 | 11.36% |
| Foresite Capital Management II, LLC | 1,586,220 | $18,670,000 | 10.50% |
| DAFNA Capital Management LLC | 636,013 | $7,486,000 | 2.81% |
| Redmile Group, LLC | 8,244,896 | $97,042,000 | 2.75% |
| Lion Point Capital, LP | 1,204,600 | $14,178,000 | 1.40% |
| Palo Alto Investors LP | 1,861,630 | $21,911,000 | 1.06% |
| SAMLYN CAPITAL, LLC | 3,517,856 | $41,405,000 | 0.87% |
| Bellevue Group AG | 4,118,806 | $48,478,000 | 0.83% |
| Rock Springs Capital Management LP | 1,562,300 | $18,388,000 | 0.66% |
| Artal Group S.A. | 850,000 | $10,005,000 | 0.40% |